Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nature Reviews. Clinical Oncology|August 28, 2024
Translating biological insights into improved management of endometrial cancerJeffrey A How, Amir A Jazaeri, Shannon N Westin, et al.
American Journal of Obstetrics and Gynecology|January 17, 2025
Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumorsAllison L Brodsky, Alejandra Flores Legarreta, Jeffrey A How, et al.
Scientific Reports|February 12, 2021
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trialJeffrey A How, Amir A Jazaeri, Pamela T Soliman, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Pregnancy Outcomes After in Utero Exposure to Immune Checkpoint InhibitorsMorgan Bou Zerdan, Bruna Kfoury, Eliane Aoun, et al.
Gynecologic Oncology|May 7, 2021
Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancerJeffrey A How, Shrina Patel, Bryan Fellman, et al.
Cancers|March 6, 2021
Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian CancerJeffrey A How, Amir A Jazaeri, Bryan Fellman, et al.
Cancers|August 12, 2022
Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical TrialsJeffrey A How, Amir A Jazaeri, Siqing Fu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 8, 2026
Oral cyclophosphamide combined with bevacizumab in recurrent heavily pre-treated ovarian cancerMostafa F Eyada, Victoria Michael, Shrina Patel, et al.
Investigational New Drugs|January 8, 2021
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trialJeffrey A How, Amir Jazaeri, Shannon N Westin, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 25, 2025
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA ConsortiumAnne M Mills, Elizabeth D Euscher, W Glenn McCluggage, et al.
Pageof 3